Gaelle Godeneche

La Rochelle, FR 
La Rochelle, FR 

Overview

Gaelle Godeneche practices practicing medicine in La Rochelle, France.

Her clinical expertise encompasses Retinal Artery Occlusion, Mesenteric Venous Thrombosis, and Erdheim-Chester Disease.

She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

La Rochelle, France
Other Locations
CHU La Milétrie
Poitiers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of a Diagnostic Strategy for Giant Cell Arteritis Based on Color Doppler Ultrasound of Temporal Arteries
Evaluation of a Diagnostic Strategy for Giant Cell Arteritis Based on Color Doppler Ultrasound of Temporal Arteries
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
Enrollment Status: Completed
Publish Date: January 24, 2024
Intervention Type: Drug
Study Drugs: Alteplase, Acetylsalicylic acid
Study Phase: Phase 3
View 1 Less Clinical Trial

9 Total Publications

Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial.
Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial.
Journal: The Lancet. Neurology
Published: May 02, 2025

Frequently Asked Questions about Gaelle Godeneche

Is Gaelle Godeneche a top-rated expert for Retinal Artery Occlusion?

MediFind is an objective health platform that identifies experts based on real-world data. Gaelle Godeneche is classified as an Experienced expert for Retinal Artery Occlusion, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gaelle Godeneche participate in research or clinical trials?

Yes. Gaelle Godeneche has published 9 articles and abstracts on conditions like Retinal Artery Occlusion. You can view a list of Gaelle Godeneche's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Godeneche's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile